NCT06866262
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +20 more
- Locations
-
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
Clinical trial condition
Metastatic Clear Cell Renal Cell Carcinoma
Explore clinical trials studying Metastatic Clear Cell Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.
26 public trials
13 recruiting studies
Metastatic Clear Cell Renal Cell Carcinoma trial results
NCT04510597
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Kingman Regional Medical Center Kingman, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
NCT06399419
- Conditions
- Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Renal Cell Carcinoma, +22 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Enrolling by Invitation
Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study
NCT07488572
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Not Yet Recruiting
Imaging Study in Metastatic Clear Cell RCC.
NCT07671417
- Conditions
- Clear-cell metastatic renal cell carcinoma, Metastatic Clear Cell Renal Cell Carcinoma
- Locations
-
- Research Facility Christchurch, New Zealand
Not Yet Recruiting
Zanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy
NCT07578025
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Not Yet Recruiting
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial
NCT07576725
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +119 more
- Locations
-
- Uganda Cancer Institute Kampala, Uganda
Not Yet Recruiting
RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy
NCT07218692
- Conditions
- Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Renal Cell Carcinoma, +23 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- City of Hope at Irvine Lennar Irvine, California, United States
NCT02848768
- Conditions
- Clear-cell metastatic renal cell carcinoma, Metastatic Clear Cell Renal Cell Carcinoma
- Locations
-
- CHU de Rennes Rennes, France
NCT06059014
- Conditions
- Clear-cell metastatic renal cell carcinoma, Metastatic Clear Cell Renal Cell Carcinoma
- Locations
-
- Centre Leon Berard Lyon, France